The ICR began a a new push to bring personalised treatments to patients, with its Tumour Profiling Unit.
ICR-developed drug abiraterone was recommended for prostate cancer patients on the NHS, and the ICR opened the Centre for Molecular Pathology.
Europe's leading cancer research centre, The Institute of Cancer Research (ICR), named eminent scientist Professor Alan Ashworth as its new Chief Executive.
Phase III trial results showed that the drug abiraterone, developed at the ICR, can significantly extend overall survival for men with advanced prostate cancer.
2009 marked the centenary year for the ICR, which began life as a small research laboratory in the Royal Marsden Hospital.
The ICR announced that the drug abiraterone could treat up to 80% of patients with aggressive and previously drug resistant prostate cancer.
ICR scientists identified two common genetic variants that could triple a person’s risk of getting bowel cancer.
The complex chain of molecular triggers involved in the development of malignant melanoma, the deadliest form of skin cancer, was published by the ICR.
Rachel Stevens took men's health into her own hands with an Everyman advertisement about warning signs of testicular cancer.
A gene crucial to the advancement and spread of bladder cancer was identified, providing a new target for drug development research.
HRH The Princess Royal, Chancellor of The University of London, officially opened the ICR’s Brookes Lawley Building at the beginning of the year.
ICR scientists linked smoking to at least 14 different types of cancer, as well as at least eight other serious medical conditions.
Scientists developed a pioneering new method for diagnosing breast cancer, helping doctors distinguish more accurately between benign and malignant tumours.
The ICR and The Royal Marsden developed a high-precision radiosurgery technique, allowing doctors to control a third of all brain tumours.
Scientists at the ICR developed a cancer chip which has revolutionised the way cancer genes are discovered.
Scientists began moving into the new extension of the Chester Beatty Laboratories in May, two years after construction started.
Last updated: 31 January 2013